Credit Suisse’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $30M | Sell |
984,959
-5,422
| -0.5% | -$182K | 0.03% | 525 |
|
|
2023
Q4 | $35.3M | Sell |
990,381
-39,942
| -4% | -$1.49M | 0.03% | 482 |
|
|
2023
Q3 | $45.1M | Sell |
1,030,323
-102,594
| -9% | -$5.01M | 0.05% | 406 |
|
|
2023
Q2 | $55.9M | Sell |
1,132,917
-4,456
| -0.4% | -$205K | 0.06% | 368 |
|
|
2023
Q1 | $47.1M | Buy |
1,137,373
+5,627
| +0.5% | +$233K | 0.05% | 417 |
|
|
2022
Q4 | $50.2M | Buy |
1,131,746
+12,916
| +1% | +$539K | 0.05% | 394 |
|
|
2022
Q3 | $43.7M | Sell |
1,118,830
-975
| -0.1% | -$44.6K | 0.05% | 414 |
|
|
2022
Q2 | $45.8M | Sell |
1,119,805
-1,589
| -0.1% | -$75.3K | 0.05% | 418 |
|
|
2022
Q1 | $73.6M | Sell |
1,121,394
-90,328
| -7% | -$5.85M | 0.06% | 328 |
|
|
2021
Q4 | $84.3M | Buy |
1,211,722
+73,376
| +6% | +$5.33M | 0.04% | 433 |
|
|
2021
Q3 | $79.2M | Sell |
1,138,346
-144,111
| -11% | -$11.1M | 0.04% | 449 |
|
|
2021
Q2 | $102M | Sell |
1,282,457
-87,409
| -6% | -$6.35M | 0.05% | 378 |
|
|
2021
Q1 | $89.8M | Buy |
1,369,866
+312,042
| +29% | +$19.2M | 0.05% | 445 |
|
|
2020
Q4 | $58.9M | Buy |
1,057,824
+1,025,105
| +3,133% | +$44.3M | 0.03% | 637 |
|
|
2020
Q3 | $1.3M | Sell |
32,719
-3,761
| -10% | -$159K | ﹤0.01% | 2738 |
|
|
2020
Q2 | $1.64M | Buy |
36,480
+13,470
| +59% | +$586K | ﹤0.01% | 2544 |
|
|
2020
Q1 | $772K | Sell |
23,010
-4,005
| -15% | -$144K | ﹤0.01% | 2855 |
|
|
2019
Q4 | $879K | Sell |
27,015
-3,945
| -13% | -$112K | ﹤0.01% | 3225 |
|
|
2019
Q3 | $771K | Buy |
30,960
+1,611
| +5% | +$46K | ﹤0.01% | 3190 |
|
|
2019
Q2 | $877K | Buy |
29,349
+4,887
| +20% | +$143K | ﹤0.01% | 3031 |
|
|
2019
Q1 | $656K | Sell |
24,462
-3,803
| -13% | -$116K | ﹤0.01% | 3191 |
|
|
2018
Q4 | $865K | Buy |
28,265
+11,660
| +70% | +$363K | ﹤0.01% | 2893 |
|
|
2018
Q3 | $581K | Sell |
16,605
-10,638
| -39% | -$337K | ﹤0.01% | 3212 |
|
|
2018
Q2 | $737K | Sell |
27,243
-2,961
| -10% | -$69.6K | ﹤0.01% | 3223 |
|
|
2018
Q1 | $619K | Buy |
30,204
+2,172
| +8% | +$39.2K | ﹤0.01% | 3251 |
|
|
2017
Q4 | $512K | Sell |
28,032
-10,789
| -28% | -$214K | ﹤0.01% | 3427 |
|
|
2017
Q3 | $869K | Buy |
38,821
+21,941
| +130% | +$496K | ﹤0.01% | 3197 |
|
|
2017
Q2 | $410K | Sell |
16,880
-1,118
| -6% | -$23.8K | ﹤0.01% | 3274 |
|
|
2017
Q1 | $345K | Sell |
17,998
-51,253
| -74% | -$898K | ﹤0.01% | 3471 |
|
|
2016
Q4 | $1.35M | Buy |
69,251
+15,608
| +29% | +$283K | ﹤0.01% | 2774 |
|
|
2016
Q3 | $849K | Buy |
53,643
+17,846
| +50% | +$274K | ﹤0.01% | 3084 |
|
|
2016
Q2 | $505K | Buy |
35,797
+10,807
| +43% | +$165K | ﹤0.01% | 3421 |
|
|
2016
Q1 | $420K | Buy |
24,990
+2,905
| +13% | +$51.1K | ﹤0.01% | 3345 |
|
|
2015
Q4 | $496K | Sell |
22,085
-593
| -3% | -$12.2K | ﹤0.01% | 3388 |
|
|
2015
Q3 | $497K | Sell |
22,678
-14,997
| -40% | -$375K | ﹤0.01% | 3390 |
|
|
2015
Q2 | $929K | Buy |
37,675
+9,307
| +33% | +$208K | ﹤0.01% | 3246 |
|
|
2015
Q1 | $581K | Buy |
28,368
+13,661
| +93% | +$265K | ﹤0.01% | 3441 |
|
|
2014
Q4 | $294K | Sell |
14,707
-10,616
| -42% | -$182K | ﹤0.01% | 4064 |
|
|
2014
Q3 | $373K | Buy |
25,323
+3,287
| +15% | +$52.4K | ﹤0.01% | 3817 |
|
|
2014
Q2 | $405K | Sell |
22,036
-25,645
| -54% | -$427K | ﹤0.01% | 3951 |
|
|
2014
Q1 | $896K | Buy |
47,681
+34,749
| +269% | +$712K | ﹤0.01% | 3226 |
|
|
2013
Q4 | $241K | Buy |
+12,932
| New | +$188K | ﹤0.01% | 4219 |
|
Other funds holding ATRC
CIP
FLAM
N
Credit Suisse's ATRC Position: Q1 2024 in Review
Credit Suisse reduced its AtriCure (ATRC) stake by 0.55% in Q1 2024, selling an estimated $182K and leaving 984,959 shares worth $30M. The position accounts for 0.03% of the portfolio, ranked #525.
Credit Suisse first reported a position in ATRC in Q4 2013 and has held it in 42 quarters since. The position peaked at $102M in Q2 2021. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.
- Credit Suisse held 984,959 shares of AtriCure worth $30M as of Q1 2024.
- Credit Suisse sold 5,422 AtriCure shares in Q1 2024, an estimated $182K.
- AtriCure made up 0.03% of Credit Suisse's portfolio in Q1 2024, its #525 holding.
- Credit Suisse first reported a position in AtriCure in Q4 2013 and has held it in 42 quarters since.
- Credit Suisse's AtriCure position peaked at $102M in Q2 2021.
- 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.